Thursday, January 03, 2013 7:18:23 PM
EPGL 5th Q and A Investor Relations 1.3.13 Archived
*Please Note: Live Conferenece Call on January 25, 2013
EPGL Med ?@EPGLMed
Welcome to the Q&A. We will answer as many questions as we can until 6:35PM EST.
EPGL Med ?@EPGLMed
Anthony, We are currently receiving inquiries from Doctors from various countries, who are getting in line to receive the first MPDD's
EPGL Med ?@EPGLMed
Some doctors, on a limited basis have been testing the devices in real world settings currently as we move toward full release.
EPGL Med ?@EPGLMed
John, The projections we have released is 15,000 units per year as the goal for worldwide distribution and sales for MPDD.
EPGL Med ?@EPGLMed
David, Wound stasis IS something EPGL team is looking into for possible applications utilizing biomems technology for better healing..
EPGL Med ?@EPGLMed
Name change to EPGL Medical Sciences, Inc. is going to happen soon, most likely late Jan, Early Feb.
EPGL Med ?@EPGLMed
Yes, the January 25th Announcement will be one you do not want to miss. Details on important items for shareholders as outlined earlier.
EPGL Med ?@EPGLMed
We have six additional devices that will be in the EPGL pipeline in addition to the MPDD and MPTT.
EPGL Med ?@EPGLMed
Yes, we will be announcing additional EPGL Team staff.
EPGL Med ?@EPGLMed
Eric, Yes, we are continuing talks with 3 Private Equity firms for potentially substantial equity investment into EPGL. We have not accepted
any offer as of yet. EPGL remains in talks with some other major medical device companies about strategic relationships.
EPGL Med ?@EPGLMed
We will never enter into any "PIPE" agreements or arrangements which will be out of line with shareholder interests.
EPGL Med ?@EPGLMed
Mr. Kirsch, both the major beneficiary holders of shares for EPGL have no intention of ever selling shares retail in the market.
EPGL Med ?@EPGLMed
Neither of the major shareholders have decided any time table for selling their interest. Their intention is to see the company through...
to substantial growth that will benefit not only current EPGL shareholders greatly, but it will benefit AJW shareholders too.
EPGL Med ?@EPGLMed
The interests of management, major shareholders and street shareholder are fully aligned towards major growth potential in the industry.
EPGL Med ?@EPGLMed
Charlie, EPGL's balance sheet has been greatly improved as a result of the restructure. Management believes we will have sufficient
capitalization to not only release and fully market the MPDD, but the subsequent devices we have in development.
EPGL Med ?@EPGLMed
We're going to go until 7PM
EPGL Med ?@EPGLMed
Yes, We will be OTC Current very shortly and yes we are continuing with plans to move to OTCQX. Nothing has changed there.
EPGL Med ?@EPGLMed
Greg, based on the number of doctors we have lined up thus far, we believe our stated sales goals will be attainable...
EPGL Med ?@EPGLMed
Yes, we are looking at first devices rolling out in second quarter to both domestic and international distribution. No, we cannot yet..
say the exact date. That will be another MAJOR ANNOUNCEMENT to come after the January 25th announcement.
EPGL Med ?@EPGLMed
Binayak, the two major shareholders have agreed to provide the necessary equity to the company any agreed upon...
strategic relationships or capitalization. So, no, there will not be another reverse split or restructuring. Management and the major..
shareholders are dedicated to bringing significant value for the shareholders. You do not bring significant value by creating uncertainty.
EPGL Med ?@EPGLMed
John, We intend for the market to become more and more aware of EPGL via release of news and information, not cheesy stock promotion.
EPGL Med ?@EPGLMed
Michael, The MPDD has not only been proven to be effective in more accurately diagnosing muscle pain, but there is published research..
available to study. There is no other device which does what MPDD does. There are hundreds of people who have had successful outcomes due to the unique capabilities of the MPDD. The device has never been widely released to the medical community.
EPGL Med ?@EPGLMed
The MPDD is more relevant than ever in today's medical environment and although it has been in development for some years, that is common in the medical device industry.
EPGL Med ?@EPGLMed
Yes, Our SEC counsel will be submitting a letter to OTC shortly and EPGL will be OTC Current Information status as previously stated.
EPGL Med ?@EPGLMed
AJW Qualified Partners is the Fund which is under court appointed supervision of Pricewaterhouse Coopers Cayman Islands.
EPGL Med ?@EPGLMed
Via PwC, AJW Funds has been issued 2.0 Billion restricted shares of EPGL common stock.
EPGL Med ?@EPGLMed
Hope that answers who AJW is.
EPGL Med ?@EPGLMed
David, EPGL has a history with the US Military and DARPA via team members. We can only say, stay tuned for future developments.
EPGL Med ?@EPGLMed
Manuel, OTCQX SEC full reporting will be .10 cents requisite share price to achieve that status. This is in our plans.
EPGL Med ?@EPGLMed
Matt, EPGL Team has talked about 24 devices on the market within 5 years. It's a goal and you asked. So there you are.
EPGL Med ?@EPGLMed
Thanks to all. Have a good night. Any questions not answered tonight will be followed up with via email.
.............................................................................................
Are you ready for the first quarter March 2013? Until then, that January 25, 2013 live conference call will be very interesting...
Im looking forward to January 25, 2013, should be VERY INTERESTING for us privileged and informed shareholders...
Also looks like they are going to achieve their sales goals for MPDD.....
No surprise there .
*Please Note: Live Conferenece Call on January 25, 2013
EPGL Med ?@EPGLMed
Welcome to the Q&A. We will answer as many questions as we can until 6:35PM EST.
EPGL Med ?@EPGLMed
Anthony, We are currently receiving inquiries from Doctors from various countries, who are getting in line to receive the first MPDD's
EPGL Med ?@EPGLMed
Some doctors, on a limited basis have been testing the devices in real world settings currently as we move toward full release.
EPGL Med ?@EPGLMed
John, The projections we have released is 15,000 units per year as the goal for worldwide distribution and sales for MPDD.
EPGL Med ?@EPGLMed
David, Wound stasis IS something EPGL team is looking into for possible applications utilizing biomems technology for better healing..
EPGL Med ?@EPGLMed
Name change to EPGL Medical Sciences, Inc. is going to happen soon, most likely late Jan, Early Feb.
EPGL Med ?@EPGLMed
Yes, the January 25th Announcement will be one you do not want to miss. Details on important items for shareholders as outlined earlier.
EPGL Med ?@EPGLMed
We have six additional devices that will be in the EPGL pipeline in addition to the MPDD and MPTT.
EPGL Med ?@EPGLMed
Yes, we will be announcing additional EPGL Team staff.
EPGL Med ?@EPGLMed
Eric, Yes, we are continuing talks with 3 Private Equity firms for potentially substantial equity investment into EPGL. We have not accepted
any offer as of yet. EPGL remains in talks with some other major medical device companies about strategic relationships.
EPGL Med ?@EPGLMed
We will never enter into any "PIPE" agreements or arrangements which will be out of line with shareholder interests.
EPGL Med ?@EPGLMed
Mr. Kirsch, both the major beneficiary holders of shares for EPGL have no intention of ever selling shares retail in the market.
EPGL Med ?@EPGLMed
Neither of the major shareholders have decided any time table for selling their interest. Their intention is to see the company through...
to substantial growth that will benefit not only current EPGL shareholders greatly, but it will benefit AJW shareholders too.
EPGL Med ?@EPGLMed
The interests of management, major shareholders and street shareholder are fully aligned towards major growth potential in the industry.
EPGL Med ?@EPGLMed
Charlie, EPGL's balance sheet has been greatly improved as a result of the restructure. Management believes we will have sufficient
capitalization to not only release and fully market the MPDD, but the subsequent devices we have in development.
EPGL Med ?@EPGLMed
We're going to go until 7PM
EPGL Med ?@EPGLMed
Yes, We will be OTC Current very shortly and yes we are continuing with plans to move to OTCQX. Nothing has changed there.
EPGL Med ?@EPGLMed
Greg, based on the number of doctors we have lined up thus far, we believe our stated sales goals will be attainable...
EPGL Med ?@EPGLMed
Yes, we are looking at first devices rolling out in second quarter to both domestic and international distribution. No, we cannot yet..
say the exact date. That will be another MAJOR ANNOUNCEMENT to come after the January 25th announcement.
EPGL Med ?@EPGLMed
Binayak, the two major shareholders have agreed to provide the necessary equity to the company any agreed upon...
strategic relationships or capitalization. So, no, there will not be another reverse split or restructuring. Management and the major..
shareholders are dedicated to bringing significant value for the shareholders. You do not bring significant value by creating uncertainty.
EPGL Med ?@EPGLMed
John, We intend for the market to become more and more aware of EPGL via release of news and information, not cheesy stock promotion.
EPGL Med ?@EPGLMed
Michael, The MPDD has not only been proven to be effective in more accurately diagnosing muscle pain, but there is published research..
available to study. There is no other device which does what MPDD does. There are hundreds of people who have had successful outcomes due to the unique capabilities of the MPDD. The device has never been widely released to the medical community.
EPGL Med ?@EPGLMed
The MPDD is more relevant than ever in today's medical environment and although it has been in development for some years, that is common in the medical device industry.
EPGL Med ?@EPGLMed
Yes, Our SEC counsel will be submitting a letter to OTC shortly and EPGL will be OTC Current Information status as previously stated.
EPGL Med ?@EPGLMed
AJW Qualified Partners is the Fund which is under court appointed supervision of Pricewaterhouse Coopers Cayman Islands.
EPGL Med ?@EPGLMed
Via PwC, AJW Funds has been issued 2.0 Billion restricted shares of EPGL common stock.
EPGL Med ?@EPGLMed
Hope that answers who AJW is.
EPGL Med ?@EPGLMed
David, EPGL has a history with the US Military and DARPA via team members. We can only say, stay tuned for future developments.
EPGL Med ?@EPGLMed
Manuel, OTCQX SEC full reporting will be .10 cents requisite share price to achieve that status. This is in our plans.
EPGL Med ?@EPGLMed
Matt, EPGL Team has talked about 24 devices on the market within 5 years. It's a goal and you asked. So there you are.
EPGL Med ?@EPGLMed
Thanks to all. Have a good night. Any questions not answered tonight will be followed up with via email.
.............................................................................................
Are you ready for the first quarter March 2013? Until then, that January 25, 2013 live conference call will be very interesting...
Im looking forward to January 25, 2013, should be VERY INTERESTING for us privileged and informed shareholders...
Also looks like they are going to achieve their sales goals for MPDD.....
No surprise there .
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
